IBDoc News

IBDoc In The Press

A blog article about IBDoc® has been published on the Gastroenterology & Endoscopy News website, a No. 1-rated independent monthly newspaper providing news and information for nearly 18,000 gastroenterologists, colorectal surgeons, hepatologists, physician assistants and nurse practitioners. In the article Toronto-based medical journalist David Wild looked at the IBDoc® system and interviewed Dr. Peter Higgins, MD, the director […]

IBDoc In The Press Read More »

IBDoc In The Press

A blog article about IBDoc® has been published on the Gastroenterology & Endoscopy News website, a No. 1-rated independent monthly newspaper providing news and information for nearly 18,000 gastroenterologists, colorectal surgeons, hepatologists, physician assistants and nurse practitioners. In the article Toronto-based medical journalist David Wild looked at the IBDoc® system and interviewed Dr. Peter Higgins, MD, the director

IBDoc In The Press Read More »

IBDoc In The Press

A blog article about IBDoc® has been published on the Gastroenterology & Endoscopy News website, a No. 1-rated independent monthly newspaper providing news and information for nearly 18,000 gastroenterologists, colorectal surgeons, hepatologists, physician assistants and nurse practitioners. In the article Toronto-based medical journalist David Wild looked at the IBDoc® system and interviewed Dr. Peter Higgins, MD, the director

IBDoc In The Press Read More »

BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test

Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a  CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis

BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test Read More »